Science Forum: Challenges in validating candidate therapeutic targets in cancer

Calico Life Sciences, United States
Memorial Sloan Kettering Cancer Center, United States
Salk Institute for Biological Studies, United States

Feb 8, 2018

https://doi.org/10.7554/eLife.32402

Open access
Copyright information

Download
A two-part list of links to download the article, or parts of the article, in various formats.
Downloads (link to download the article as PDF)
- Article PDF
Open citations (links to open the citations from this article in various online reference manager services)
- Mendeley
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Jeffrey Settleman

Charles L Sawyers

Tony Hunter

(2018)
Science Forum: Challenges in validating candidate therapeutic targets in cancer

eLife 7:e32402.

https://doi.org/10.7554/eLife.32402
- Download BibTeX
- Download .RIS
Cite
CommentOpen annotations (there are currently 0 annotations on this page).
Share

1 table

Tables

Table 1

Articles suggesting a link between MELK and human cancers.

The 33 articles listed in column 1 of this table suggest that MELK has a role in a variety of human cancers, which makes in a candidate therapeutic target for cancer drugs. Columns 2–5 indicate …

https://doi.org/10.7554/eLife.32402.002

	Articles reporting that MELK expression is up-regulated in various human cancers	Articles reporting an association between increased MELK expression and poor clinical prognosis	Articles reporting efficacy of MELK-targeted RNAi in cancer cell lines and/or xenograft tumor models	Articles reporting efficacy with small-molecule inhibitors of MELK in cancer cell lines and/or xenograft tumor models	Articles that made use of the MELK inhibitor OTS167 (also known as OTSSP167)
Gray et al. (2005)	x		x
Lin et al. (2007)	x		x
Marie et al. (2008)	x	x	x
Nakano et al. (2008)	x	x	x
Nakano et al. (2009)	x		x
Pickard et al. (2009)	x	x	x
Hebbard et al. (2010)			x
Choi and Ku (2011)			x
Chung et al. (2012)				x	x
Gu et al. (2013)	x	x	x
Kuner et al. (2013)	x	x
Minata et al. (2014)			x	x
Wang et al. (2014)	x		x	x	x
Du et al. (2014)	x	x	x
Alachkar et al. (2014)	x	x	x	x	x
Beke et al. (2015)				x
Li et al. (2016)	x	x	x	x	x
Inoue et al. (2016)	x		x	x	x
Chung et al. (2016)				x	x
Kato et al. (2016)				x	x
Touré et al., 2016			x	x
Wang et al. (2016)			x	x	x
Stefka et al. (2016)				x	x
Xia et al. (2016)	x	x	x
Speers et al., 2016	x	x	x	x	x
Hiwatashi et al., 2016	x	x
Kohler et al. (2017)	x	x		x	x
Simon et al. (2017)			x	x	x
Edupuganti et al. (2017)				x
Liu et al., 2017	x	x	x	x	x
Matsuda et al. (2017)			x
Bolomsky et al., 2017	x	x		x	x
Janostiak et al., 2017	x	x	x	x	x